Convergent
Website Evolution for Biopharma
For whatever reason, one of the first things biopharmas do is get a website.
Convergent decided to wait until they had promising Phase I data in hand.
You might think that’s weird, but it’s actually pretty cool. That’s because every website needs to claim something, then provide some kind of proof. And it’s way cooler when you have impressive data.
Stealth Mode
The first step was to sift through the data and pull out just enough to get investors interested – without showing too much.
In this case, a custom illustration was created to show how the prostate specific membrane antigen (PSMA) binds to the cell membrane.
In addition to their solid data, Convergent new website establishes a solid messaging and branding foundation – just what you need to start attracting Series-B investors.
Need creative ideas for your agency? Check out Rushminute’s Virtual Creative Services.
